Genus (LON:GNS – Get Free Report) had its price objective upped by stock analysts at Berenberg Bank from GBX 3,050 to GBX 3,250 in a report released on Friday, MarketBeat reports. The firm presently has a “buy” rating on the stock. Berenberg Bank’s price target would indicate a potential upside of 16.24% from the stock’s current price.
GNS has been the topic of several other reports. Deutsche Bank Aktiengesellschaft boosted their target price on Genus from GBX 2,900 to GBX 3,100 and gave the stock a “buy” rating in a report on Wednesday, November 19th. Shore Capital lifted their price objective on Genus from GBX 2,900 to GBX 3,000 and gave the company a “buy” rating in a research report on Wednesday, November 19th. Three equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average target price of GBX 3,116.67.
Check Out Our Latest Analysis on GNS
Genus Price Performance
Genus Company Profile
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.
Read More
- Five stocks we like better than Genus
- 53% Gains In 4 Years. Then 51% In Under 11 Months.
- Is Elon Preparing for a Silver Shock?
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Do not delete, read immediately
- The Crash Has Already Started (Most Just Don’t See It Yet)
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.
